 - Patients must not have had prior systemic biologic response modifier therapy; patients must not have had chemotherapy, hormonal or biologic therapy within 4 weeks 6 weeks for nitrosoureas or mitomycin C prior to entering the study or have recovered from adverse events due to agents administered more than 4 weeks earlier 